S. Jane's questions to Recursion Pharmaceuticals Inc (RXRX) leadership • FY 2024
Question
S. Jane asked about plans to diversify revenue streams beyond current partnerships and about leadership's confidence in successfully bringing its own drug candidates to market.
Answer
CFO Ben Taylor stated that while they evaluate other revenue streams, the economic terms of their current pharma partnerships are excellent and set a very high bar to exceed. CEO Christopher Gibson expressed strong confidence in their platform's ability to generate better medicines over time, noting that their broad pipeline of internal and partnered programs mitigates the bimodal risk typical of biotech companies.